Potentially inappropriate medication in older participants of the Berlin Aging Study II (BASE-II) #_#x2013; Sex differences and associations with morbidity and medication use
暂无分享,去创建一个
I. Demuth | R. Kreutz | M. König | J. Bolbrinker | E. Steinhagen | Sarah ToepferID | Maximilian König | Juliane Bolbrinker
[1] Allison H. Oakes,et al. Factors associated with potentially inappropriate medication use in community‐dwelling older adults in the United States: a systematic review , 2019, The International journal of pharmacy practice.
[2] A. Nobili,et al. Drug-drug interactions involving CYP3A4 and p-glycoprotein in hospitalized elderly patients. , 2019, European journal of internal medicine.
[3] E. Hak,et al. Trends in polypharmacy and dispensed drugs among adults in the Netherlands as compared to the United States , 2019, PloS one.
[4] C. Walker. Are All Oral COX-2 Selective Inhibitors the Same? A Consideration of Celecoxib, Etoricoxib, and Diclofenac , 2018, International journal of rheumatology.
[5] M. Zins,et al. Association Between Potentially Inappropriate Medications and Frailty in the Early Old Age: A Longitudinal Study in the GAZEL Cohort. , 2018, Journal of the American Medical Directors Association.
[6] F. Jessen,et al. Perspective of elderly patients on chronic use of potentially inappropriate medication – Results of the qualitative CIM-TRIAD study , 2018, PloS one.
[7] V. Paniz,et al. Potentially inappropriate medication in the elderly: a systematic review of validated explicit criteria , 2018, European Journal of Clinical Pharmacology.
[8] L. Hemmy,et al. Over-the-Counter Supplement Interventions to Prevent Cognitive Decline, Mild Cognitive Impairment, and Clinical Alzheimer-Type Dementia , 2018, Annals of Internal Medicine.
[9] Charles E. Leonard,et al. Comparative risk of serious hypoglycemia with oral antidiabetic monotherapy: A retrospective cohort study , 2018, Pharmacoepidemiology and drug safety.
[10] Gillian E. Caughey,et al. What is polypharmacy? A systematic review of definitions , 2017, BMC Geriatrics.
[11] A. L. Lucchetti,et al. Comparison of four criteria for potentially inappropriate medications in Brazilian community‐dwelling older adults , 2017, Geriatrics & gerontology international.
[12] U. Dydak,et al. Association of exposure to manganese and iron with relaxation rates R1 and R2*‐ magnetic resonance imaging results from the WELDOX II study , 2017, Neurotoxicology.
[13] D. Fick,et al. Determinants of Potentially Inappropriate Medication Use among Community‐Dwelling Older Adults , 2017, Health services research.
[14] A. Majeed,et al. Current and future perspectives on the management of polypharmacy , 2017, BMC Family Practice.
[15] S. Albert,et al. Over-the-counter medications containing diphenhydramine and doxylamine used by older adults to improve sleep , 2017, International Journal of Clinical Pharmacy.
[16] M. Gustafsson,et al. An evaluation of the prevalence of potentially inappropriate medications in older people with cognitive impairment living in Northern Sweden using the EU(7)-PIM list , 2017, European Journal of Clinical Pharmacology.
[17] E. Steinhagen-Thiessen,et al. Prevalence of Impaired Kidney Function in the German Elderly: Results from the Berlin Aging Study II (BASE-II) , 2017, Gerontology.
[18] H. Brenner,et al. Is Polypharmacy Associated with Frailty in Older People? Results From the ESTHER Cohort Study , 2017, Journal of the American Geriatrics Society.
[19] E. Steinhagen-Thiessen,et al. Relative Leukocyte Telomere Length, Hematological Parameters and Anemia - Data from the Berlin Aging Study II (BASE-II) , 2016, Gerontology.
[20] E. Mehuys,et al. Potentially inappropriate prescribing in community-dwelling older people across Europe: a systematic literature review , 2015, European Journal of Clinical Pharmacology.
[21] M. Petzold,et al. Potentially inappropriate prescribing and adverse drug reactions in the elderly: a population-based study , 2015, European Journal of Clinical Pharmacology.
[22] J. Fastbom,et al. Association between drug‐specific indicators of prescribing quality and quality of drug treatment: a validation study , 2015, Pharmacoepidemiology and drug safety.
[23] G. Meyer,et al. The EU(7)-PIM list: a list of potentially inappropriate medications for older people consented by experts from seven European countries , 2015, European Journal of Clinical Pharmacology.
[24] Michael L. Johnson,et al. Potentially Inappropriate Anticholinergic Medication Use in Community-Dwelling Older Adults: A National Cross-Sectional Study , 2015, Drugs & Aging.
[25] Paul Gallagher,et al. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2 , 2014, Age and ageing.
[26] O. Senn,et al. Potentially Inappropriate Medication Use in Older Patients in Swiss Managed Care Plans: Prevalence, Determinants and Association with Hospitalization , 2014, PloS one.
[27] Shu-Chen Li,et al. Cohort profile: The Berlin Aging Study II (BASE-II). , 2014, International journal of epidemiology.
[28] P. Ihle,et al. Prescribing potentially inappropriate medication (PIM) in Germany's elderly as indicated by the PRISCUS list. An analysis based on regional claims data , 2013, Pharmacoepidemiology and drug safety.
[29] A. Calderón-Larrañaga,et al. Multimorbidity, polypharmacy, referrals, and adverse drug events: are we doing things well? , 2012, The British journal of general practice : the journal of the Royal College of General Practitioners.
[30] J. Hippisley-Cox,et al. Antidepressant use and risk of adverse outcomes in older people: population based cohort study , 2011, BMJ : British Medical Journal.
[31] M. Egger,et al. Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis , 2011, BMJ : British Medical Journal.
[32] J. Manson,et al. Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women. , 2010, JAMA.
[33] Sven Schmiedl,et al. Potentially inappropriate medications in the elderly: the PRISCUS list. , 2010, Deutsches Arzteblatt international.
[34] D. Nathan. Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A Consensus Statement of the American Diabetes Association and the European Association for the Study of Diabetes , 2009, Diabetes Care.
[35] Lewis H Kuller,et al. Ginkgo biloba for prevention of dementia: a randomized controlled trial. , 2008, JAMA.
[36] P. Gallagher,et al. STOPP (Screening Tool of Older Person's Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. , 2008, International journal of clinical pharmacology and therapeutics.
[37] L. Merle,et al. Potentially inappropriate medications in the elderly: a French consensus panel list , 2007, European Journal of Clinical Pharmacology.
[38] M. Beers,et al. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. , 2003, Archives of internal medicine.
[39] G. Harewood. Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs. , 1999, The New England journal of medicine.
[40] M. Beers,et al. Explicit criteria for determining potentially inappropriate medication use by the elderly. An update. , 1997, Archives of internal medicine.
[41] R. Tamblyn,et al. Defining inappropriate practices in prescribing for elderly people: a national consensus panel. , 1997, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[42] G. Waldemar,et al. Changes in the Prevalence of Polypharmacy in People with and without Dementia from 2000 to 2014: A Nationwide Study. , 2019, Journal of Alzheimer's disease : JAD.
[43] P. Thürmann,et al. [Which factors are associated with the use of potentially inadequate medications (PIM) in the elderly? : Results from the German health interview and examination survey (DEGS1)]. , 2018, Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz.
[44] E. Steinhagen-Thiessen,et al. Polypharmacy as a Risk Factor for Clinically Relevant Sarcopenia: Results From the Berlin Aging Study II , 2017, The journals of gerontology. Series A, Biological sciences and medical sciences.
[45] R. Linder,et al. [Physicians' prescription behavior of potentially inappropriate medications for elderly people: an analysis using the PRISCUS list based on TK routine data]. , 2014, Deutsche medizinische Wochenschrift.
[46] J. Luykx,et al. [Choosing the correct benzodiazepine: mechanism of action and pharmacokinetics]. , 2012, Nederlands tijdschrift voor geneeskunde.
[47] C. Mackenzie,et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.